Test Date: | Jun 13, 2018 |
---|---|
Pub. Date: | Jun 14, 2018 |
Src Location: | Online |
Submitter Loc: | Los Angeles, CA United States |
Color: | White |
Size: | 50 mg, 6.10 mm x 17.40 mm |
Data Source: | DrugsData (EcstasyData) |
Tested by: | DDL |
Lab's ID: | 20180600001 |
In June, 2018, the lab analyzed this sample and reported only the presence of AMB-FUBINACA and 'no 2C-B detected'.
On September 23, 2018, imdeeami on Reddit pointed out that the field reagent color results were inconsistent between this sample and a previous sample containing only AMB-FUBINACA. See https://www.reddit.com/r/ReagentTesting/comments/9i8fgv/puzzling_reagent_tests_at_ecstasydata/.
We asked the lab to re-homogenize the powder and re-analyze it, and photograph the reagent results from the new test. Upon re-analysis in Sep 2018, the lab found that the sample did in fact contain 2-CB!
We believe that the contents of the capsule were not homogenized (mixed well) and so the tiny portion of powder from inside the capsule that the lab analyzed via GC/MS contained no 2C-B, but obviously the tiny portion of powder from the capsule that was tested with reagents and photographed did contain 2C-B. That would explain the difference in color changes between this sample and the previous AMB-FUBINACA-only sample (Sample #6237).
We're working with the lab to improve the testing procedures to minimize the issue of hotspots and coldspots within submitted capsules and powders.
The second and third photos are of the same re-test. Photo 3 was taken after what we call 'spreading' the reaction spots to make it easier to see the color. The only difference between photo 2 and photo 3 is that the lab technician used a non-reactive tool to swirl and spread the reaction spot. Photo 2 and Photo 3 were taken within a minute of each other.